Skip to main content
Log in

Cracking the moody brain: Lifting the mood with ketamine

  • Between Bedside and Bench
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: The rapid-acting antidepressant effects of ketamine and the potential role of synaptogenic and neurotrophic mechanisms in depression.

References

  1. Trullas, R. & Skolnick, P. Eur. J. Pharmacol. 185, 1–10 (1990).

    Article  CAS  Google Scholar 

  2. Skolnick, P. et al. Pharmacopsychiatry 29, 23–26 (1996).

    Article  CAS  Google Scholar 

  3. Maeng, S. et al. Biol. Psychiatry 63, 349–352 (2008).

    Article  CAS  Google Scholar 

  4. Li, N. et al. Science 329, 959–964 (2010).

    Article  CAS  Google Scholar 

  5. Berman, R.M. et al. Biol. Psychiatry 47, 351–354 (2000).

    Article  CAS  Google Scholar 

  6. Zarate, C.A. Jr. et al. Arch. Gen. Psychiatry 63, 856–864 (2006).

    Article  CAS  Google Scholar 

  7. Mathew, S.J. et al. Int. J. Neuropsychopharmacol. 13, 71–82 (2010).

    Article  CAS  Google Scholar 

  8. aan het Rot, M. et al. Biol. Psychiatry 67, 139–145 (2010).

    Article  CAS  Google Scholar 

  9. Preskorn, S.H. et al. J. Clin. Psychopharmacol. 28, 631–637 (2008).

    Article  CAS  Google Scholar 

  10. Olney, J.W., Labruyere, J. & Price, M.T. Science 244, 1360–1362 (1989).

    Article  CAS  Google Scholar 

  11. Perry, E.B. Jr. et al. Psychopharmacology (Berl.) 192, 253–260 (2007).

    Article  CAS  Google Scholar 

  12. Price, R.B., Nock, M.K., Charney, D.S. & Mathew, S.J. Biol. Psychiatry 66, 522–526 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James W Murrough.

Ethics declarations

Competing interests

D.S.C. and Mount Sinai School of Medicine have been named on a use patent of ketamine for the treatment of depression. If ketamine were shown to be effective in the treatment of depression and approved by the US Food and Drug Administration for this indication, D.S.C. and Mount Sinai School of Medicine could benefit financially.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murrough, J., Charney, D. Cracking the moody brain: Lifting the mood with ketamine. Nat Med 16, 1384–1385 (2010). https://doi.org/10.1038/nm1210-1384

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1210-1384

  • Springer Nature America, Inc.

This article is cited by

Navigation